---
title: "Leqvio (inclisiran), all indications: Access and coverage questions"
description: "Access and coverage questions on Leqvio (inclisiran) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and billing, Cost and coverage, Prior authorization, and Patient support. Questions: What is the NDC for Leqvio? What is the J-code for Leqvio? Which claim modifiers apply to Leqvio (JZ and TB)? How is the Leqvio NDC entered on a claim form? 21 further questions follow. 25 questions quoted from 11 sources."
canonical: "https://www.evicenter.com/medical-information/leqvio/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Leqvio (inclisiran), all indications: Access and coverage questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Leqvio](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf)  
Indication pages: [Hypercholesterolemia](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia)

## Access and billing

<a id="leqvio-ndc"></a>

### What is the NDC for Leqvio?

> “National Drug Code<sup>4</sup>	10-digit: 0078-1000-60
> 11-digit: 00078-1000-60”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=National%20Drug,11%2Ddigit%3A%2000078%2D1000%2D60)

> “Carton containing 1 single-dose prefilled syringe: 
> NDC 0078-1000-60”

Source: [LEQVIO: Prescribing information, page 16, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=16)

<a id="leqvio-j-code"></a>

### What is the J-code for Leqvio?

> “Healthcare Common Procedure Coding System Level II Code<sup>1,2</sup>”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=Healthcare%20Common%20Procedure%20Coding%20System%20Level%20II)

> “J1306 - Injection, inclisiran, 1 mg;
> Billing units: 284”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=J1306%20%2D%20Injection%2C%20inclisiran%2C%201,Billing%20units%3A%20284)

<a id="leqvio-claim-modifiers"></a>

### Which claim modifiers apply to Leqvio (JZ and TB)?

> “JZ modifier: Effective July 1, 2023, providers and suppliers are required to report the JZ modifier on all claims that bill for drugs from single-dose containers that are separately payable under Medicare Part B when there are no discarded amounts.
>
> TB modifier: Starting January 1, 2025, the updated CMS guidance requires 340B covered entities to only report the TB modifier on claims for products acquired through the 340B program. Do not use the JG modifier for claims with dates of service after December 31, 2024. This update will impact Medicare providers and suppliers who bill for separately payable Part B drugs and biologics and participate in the 340B Pricing Program.”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=JZ%20modifier%3A%20Effective%20July%201%2C,in%20the%20340B%20Pricing%20Program.)

<a id="leqvio-ndc-claim-form"></a>

### How is the Leqvio NDC entered on a claim form?

> “Box 24A 
> In the non-shaded area, list the date of 
> service. In the shaded area, give a detailed 
> drug description. List the N4 indicator first, 
> then the 11-digit NDC number. Third is the 
> unit of measurement qualifier; the unit 
> quantity is listed at the end. 
> Example N400078100060ML1.5”

Source: [LEQVIO: Billing & Coding Guide, page 6, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=6)

Note: The passage is from the sample CMS-1500 claim form for a physician's office in the Billing and Coding Guide.

<a id="leqvio-place-of-service"></a>

### Which place of service codes apply to Leqvio administration?

> “Place of Service (POS) Codes<sup>5</sup>	
>
> 11 – Office
> Location, other than a hospital, skilled nursing facility (SNF), military treatment facility, community health center, state or local public health clinic, or intermediate care facility (ICF), where the health care professional routinely provides health examinations, diagnosis, and treatment of illness or injury on an ambulatory basis.
>
> 22 – On campus – Outpatient Hospital
> A portion of a hospital's main campus that provides diagnostic, therapeutic (both surgical and nonsurgical), and rehabilitation services to sick or injured persons who do not require hospitalization or institutionalization.”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=Place%20of%20Service%20%28POS%29,not%20require%20hospitalization%20or%20institutionalization.)

<a id="leqvio-buy-and-bill"></a>

### How does buy-and-bill work for Leqvio?

> “Buy-and-bill is an option for acquiring medications covered under the medical benefit that are administered by a health care provider
> Drugs covered under Medicare Part B (fee-for-service) must be acquired through this method
>
> The buy-and-bill process takes place in 5 simple steps:
>
> Verify benefits
> HCP/office staff member confirms the patient’s benefits with their medical insurance plan
> If you need assistance, reach out to the LEQVIO Service Center ↗
> Order LEQVIO through a distributor
> HCP/office staff member orders LEQVIO, assuming responsibility for storing and handling. A list of authorized LEQVIO distributors and group purchasing organizations (GPOs) can be found below. If your practice is part of a system that uses a central purchasing model, then the buy-and-bill process steps may not apply
> Schedule the patient's appointment and administer LEQVIO
> HCP administers LEQVIO in their office
> Remember to help your commercially insured patients enroll in the LEQVIO<sup>®</sup> Co-pay Program
> Submit claim
> HCP/office staff member submits claim to payer for reimbursements
> Manage reimbursement
> HCP/office staff member receives reimbursement from payer and collects balance due (if any) from the patient  
> Submit and manage co-pay claim for reimbursement for your commercially insured patients who are enrolled in the LEQVIO Co-pay Program”

Source: [LEQVIO: How to Get LEQVIO | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/acquiring-leqvio#:~:text=Buy%2Dand%2Dbill%20is%20an%20option%20for,in%20the%20LEQVIO%20Co%2Dpay%20Program)

<a id="leqvio-distributors"></a>

### Which distributors sell Leqvio for buy-and-bill?

> “If you intend to buy-and-bill, LEQVIO can be ordered through our authorized distributors.
>
> Novartis does not recommend the use of any particular distributor.
>
> Distributor	Contact Info	Website
> Anda	Phone: 1-855-297-0081
>
> Fax: 1-855-546-8521	https://www.andanet.com ↗
> Cardinal Health Specialty Pharmaceuticals	Phone: 1-866-677-4844	https://specialtyonline.cardinalhealth.com/ ↗
> Cencora Besse Medical (physician distribution)	Phone: 1-800-543-2111
>
> Fax: 1-800-543-8695	https://www.besse.com ↗
> Cencora Oncology Supply (practice distribution)	Phone: 1-800-633-7555
>
> Fax: 1-800-248-8205	https://www.oncologysupply.com ↗
> Cencora Specialty Distribution (health systems and specialty pharmacy)	Phone: 1-800-746-6273
>
> Fax: 1-800-547-9413	https://www.asdhealthcare.com ↗
> CuraScript SD	Phone: 1-877-599-7748
>
> Fax: 1-800-862-6208	https://curascriptsd.com ↗
> Henry Schein	Phone: 1-800-772-4346
>
> Fax: 1-800-329-9109	https://www.henryschein.com ↗
> McKesson Medical-Surgical	Phone: 1-866-625-2679	https://mms.mckesson.com ↗
> McKesson MPB	Phone: 1-877-625-2566
>
> Fax: 1-888-752-7626	https://connect.mckesson.com ↗
> McKesson Specialty Care Distribution	Phone: 1-855-477-9800
>
> Fax: 1-800-800-5673	https://mscs.mckesson.com ↗
> Metro Medical (A Cardinal Health Company)	Phone: 1-800-768-2002
>
> Fax: 1-615-256-4194	https://metromedicalorder.com ↗”

Source: [LEQVIO: How to Get LEQVIO | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/acquiring-leqvio#:~:text=If%20you%20intend%20to%20buy%2Dand%2Dbill%2C,https%3A%2F%2Fmetromedicalorder.com)

Note: The distributor list is as captured on November 14, 2026.

<a id="leqvio-specialty-pharmacy"></a>

### Can Leqvio be ordered through a specialty pharmacy?

> “Specialty pharmacy (SP)
> A patient’s plan may restrict drug coverage under the pharmacy benefit using an SP
> LEQVIO ordered through an SP must be given to the specific patient for whom it was ordered (unlike through buy-and-bill, in which LEQVIO can be given to any patient for whom it’s prescribed)
>
> The SP process
> The patient’s plan restricts coverage to the pharmacy benefit, or HCP prefers this pathway and the patient is eligible for the pharmacy benefit.
>
> 1. Send Rx: HCP sends prescription via e-prescribing platform to SP.
>
> 2. Benefits verification (BV): SP conducts BV, receives Statement of Benefits, and coordinates prior authorization of precertification as needed.
>
> 3. Patient payment: Patient pays co-pay/coinsurance or deductible when SP dispenses LEQVIO.
>
> 4. Send drug: SP sends LEQVIO to HCP practice or as dictated by insurance coverage.
>
> 5. Store and schedule: HCP practice schedules patient injection visit and stores LEQVIO if needed.
>
> 6. Administer: HCP administers LEQVIO to the patient.
>
> 7. Collect for services: HCP practice collects patient co-pay for any services (administration fee).”

Source: [LEQVIO: How to Get LEQVIO | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/acquiring-leqvio#:~:text=Specialty%20pharmacy%20%28SP%29,for%20any%20services%20%28administration%20fee%29.)

<a id="leqvio-alternate-site-of-care"></a>

### Can Leqvio be given outside my office (alternate site of care)?

> “Alternate Site of Care
>
> Administration takes place at a site other than your office*
>
> Practice locates and refers the patient to an alternate site of care, which then handles the following:
>
> Benefits verification
> Prior authorization support
> Acquisition of LEQVIO
> Administration of LEQVIO
> Submitting claims for reimbursement”

Source: [LEQVIO: How to Get LEQVIO | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/acquiring-leqvio#:~:text=Alternate%20Site%20of%20Care,Submitting%20claims%20for%20reimbursement)

> “*May include a clinic, hospital outpatient department, or another physician’s office.”

Source: [LEQVIO: How to Get LEQVIO | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/acquiring-leqvio#:~:text=%2AMay%20include%20a%20clinic%2C%20hospital%20outpatient%20department%2C%20or%20another%20physician%E2%80%99s%20office.)

> “Try our LEQVIO locator tool to find an ASOC that is convenient for you and your patient.<sup>†</sup>
>
> Visit LEQVIO Locator Tool
> *May include a clinic, hospital outpatient department, or another physician’s office.
> <sup>†</sup>Novartis does not recommend the use of any specific ASOC. The LEQVIO locator is not an exhaustive list of ASOCs. The list of ASOCs is maintained by a third party, and inclusion in the locator tool is not an endorsement by Novartis.”

Source: [LEQVIO: Start Your Patients | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/start-your-patients#:~:text=Try%20our%20LEQVIO%20locator%20tool,not%20an%20endorsement%20by%20Novartis.)

## Cost and coverage

<a id="leqvio-medical-benefit"></a>

### Is Leqvio covered under the medical benefit or pharmacy benefit?

> “Because it is administered by an HCP, LEQVIO is covered primarily under the medical benefit.<sup>1</sup>”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=Because%20it%20is%20administered%20by,covered%20primarily%20under%20the%20medical)

> “Most payers cover physician-administered products such as LEQVIO under a medical benefit rather 
> than a pharmacy benefit. In the case of Medicare, LEQVIO will typically be covered under Part B. 
> However, private payers and Medicaid may require that physicians obtain LEQVIO through a specialty 
> pharmacy. Specialty pharmacies may bill the payer under the medical or pharmacy benefit, depending 
> on what that payer requires. Additionally, Medicare Advantage payers may cover LEQVIO in a similar 
> way to private payers depending on the benefit design of the plan.”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

<a id="leqvio-insurance-coverage"></a>

### Is Leqvio covered by insurance?

> “9 out of 10 patients have confirmed coverage under the medical benefit for LEQVIO”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=9%20out%20of%2010%20patients,the%20medical%20benefit%20for%20LEQVIO)

> “Private payers may cover 
> LEQVIO and the medical 
> services associated with its 
> administration. However, there 
> may be restrictions on coverage, 
> such as special requirements for 
> distribution and precertification. 
> Private payers may also vary in 
> the payment methods they use 
> to reimburse the sites of service 
> where LEQVIO is administered”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

Note: The coverage figure is the manufacturer's statement, as captured on November 14, 2026. The line carries no reference marker; the page's reference list cites Novartis data on file (LEQVIO Coverage and Affordability, 2025).

<a id="leqvio-medicare"></a>

### Does Medicare cover Leqvio?

> “Your traditional Medicare Part B patients are eligible to start LEQVIO—with or without a statin<sup>1</sup>”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=Your%20traditional%20Medicare%20Part%20B,start%20LEQVIO%E2%80%94with%20or%20without%20a)

> “In the case of Medicare, LEQVIO will typically be covered under Part B.”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

> “Medicare typically covers and 
> separately reimburses drugs 
> provided in the physician’s 
> office as well as most drugs 
> provided in the hospital 
> outpatient department that 
> are not self-administered and 
> are provided incident to a 
> physician service.”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

> “Coverage under Medicare 
> Advantage can vary by plan. 
> Providers should check with 
> the patient’s plan for specific 
> coverage and payment 
> information”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

Note: The affordability page statement is as captured on November 14, 2026. The LEQVIO Co-pay Program is not valid under Medicare.

<a id="leqvio-medicare-cost"></a>

### How much does Leqvio cost with traditional Medicare?

> “90% of patients have supplemental plans and MAY PAY AS LITTLE AS $0”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=90%25%20of%20patients%20have%20supplemental,PAY%20AS%20LITTLE%20AS%20%240)

Note: The figure appears under the traditional Medicare tab of the affordability page, as captured on November 14, 2026. The line carries no reference marker; the page's reference list cites Novartis data on file (LEQVIO Coverage and Affordability, 2025). The LEQVIO Co-pay Program is not valid under Medicare.

<a id="leqvio-medicaid"></a>

### Does Medicaid cover Leqvio?

> “Medicaid coverage and 
> payment for LEQVIO can 
> vary by state or by the 
> specific managed Medicaid 
> plan. Providers should check 
> with the state program or 
> plan for specific coverage 
> information and all payer 
> types for fee schedules”

Source: [LEQVIO: Billing & Coding Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11607044_LEQ_Billing_and_Coding_Guide-Digital-Label_Update-2-26/FA-11607044.PDF#page=3)

<a id="leqvio-medicaid-cost"></a>

### How much does Leqvio cost with Medicaid?

> “For Medicaid patients, LEQVIO may be available for less than $10”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=For%20Medicaid%20patients%2C%20LEQVIO%20may%20be%20available%20for%20less%20than%20%2410)

Note: The statement is as captured on November 14, 2026. The line carries no reference marker; the page's reference list cites Novartis data on file (LEQVIO Coverage and Affordability, 2025). The LEQVIO Co-pay Program is not valid under Medicaid.

<a id="leqvio-commercial-cost"></a>

### How much do commercially insured patients pay for Leqvio?

> “86% of the commercial patients who utilized the LEQVIO<sup>®</sup> Co-pay Program paid $0<sup>1</sup>”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=86%25%20of%20the%20commercial%20patients,Co%2Dpay%20Program%20paid)

> “80% of commercial patients paid less than $10, and 71% paid $0”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=80%25%20of%20commercial%20patients%20paid%20less%20than%20%2410%2C%20and%2071%25%20paid%20%240)

Note: The two figures describe different groups and data sets, both as captured on November 14, 2026: patients who used the LEQVIO Co-pay Program (patient support page, citing Novartis data on file, 2024) and commercial patients (affordability page; the line carries no reference marker, and the page's reference list cites Novartis data on file, 2025). The co-pay program is valid only for patients with commercial insurance, and per-treatment maximums and an annual benefit cap apply.

<a id="leqvio-copay-program"></a>

### Is there a Leqvio copay card or copay program?

> “Your eligible patients with commercial insurance may pay as little as $0.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=Your%20eligible%20patients%20with%20commercial%20insurance%20may%20pay%20as%20little%20as%20%240.)

> “No financial information required. Subject to terms and conditions. Limitations apply.*”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=No%20financial%20information%20required.%20Subject%20to%20terms%20and%20conditions.%20Limitations%20apply.%2A)

> “*Limitations apply. Valid only for those with commercial insurance. The Program may include the Co-pay Card, Payment Card (if applicable), and Rebate. Per-treatment maximums and an annual benefit cap apply. For patients covered under the medical benefit, rebate for out-of-pocket costs will be assigned directly to provider, unless patient requests direct reimbursement. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state health care program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or health care savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=%2ALimitations%20apply.%20Valid%20only%20for,at%20any%20time%20without%20notice.)

Note: The program terms are as captured on November 14, 2026.

<a id="leqvio-copay-enrollment"></a>

### How do patients enroll in the Leqvio copay program?

> “Patients can directly enroll in co-pay services by signing up via Start.LEQVIO.com or by calling 833-LEQVIO2 (833-537-8462) ↗.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=Patients%20can%20directly%20enroll%20in,or%20by%20calling%20833%2DLEQVIO2%20%28833%2D537%2D8462%29)

> “Enroll your patients electronically for all services, including the LEQVIO Co-pay Program”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=Enroll%20your%20patients%20electronically%20for%20all%20services%2C%20including%20the%20LEQVIO%20Co%2Dpay%20Program)

> “*Limitations apply. Valid only for those with commercial insurance.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=%2ALimitations%20apply.%20Valid%20only%20for%20those%20with%20commercial%20insurance.)

<a id="leqvio-coverage-lookup"></a>

### How can I check Leqvio coverage for a specific health plan?

> “Search by plan name
> or
> Search by ZIP code
> or
> Search by NPI number”

Source: [LEQVIO: Coverage Lookup Tool | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/coverage-tool#:~:text=Search%20by%20plan%20name,Search%20by%20NPI%20number)

> “The information provided is not a guarantee of coverage. Actual benefits are determined by each plan administrator in accordance with its policies and procedures. Because formularies change and many health plans offer more than one formulary, please check with the health plan to confirm coverage for individual patients.”

Source: [LEQVIO: Coverage Lookup Tool | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/coverage-tool#:~:text=The%20information%20provided%20is%20not,confirm%20coverage%20for%20individual%20patients.)

> “Sources: Formulary data are provided by Managed Markets Insight & Technology, LLC, and are current as of October 2026.”

Source: [LEQVIO: Coverage Lookup Tool | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/coverage-tool#:~:text=Sources%3A%20Formulary%20data%20are%20provided,current%20as%20of%20October%202026.)

## Prior authorization

<a id="leqvio-prior-authorization"></a>

### Does Leqvio require prior authorization?

> “Since every plan manages LEQVIO® differently, you may run into various restrictions to coverage even 
> if prescribing LEQVIO is the right decision clinically.
> This guide is intended to be a resource for you to use if your patient is faced with common insurance 
> restrictions like a prior authorization (PA), step edit, or a plan not having a policy in place for LEQVIO.”

Source: [LEQVIO: Prior Authorization & Appeals Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612139_LEQ_PA_and_Appeals_Guide-Digital-Label_Update-2-26/FA-11612139.PDF#page=3)

> “Your patients with traditional Medicare will likely not require a PA to access 
> LEQVIO® because Medicare covers medically necessary use of certain 
> outpatient prescription drugs”

Source: [LEQVIO: Buy-and-Bill 5-Step Guide, page 5, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11608875_LEQ_Buy_and_Bill_5_Step_Guide-Digital-Label_Update-2-26/FA-11608875.PDF#page=5)

> “Your patients with Medicare Advantage or commercial insurance may need 
> to submit a PA for LEQVIO”

Source: [LEQVIO: Buy-and-Bill 5-Step Guide, page 5, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11608875_LEQ_Buy_and_Bill_5_Step_Guide-Digital-Label_Update-2-26/FA-11608875.PDF#page=5)

> “For all Medicare patients,
>
> no prior authorization is required”

Source: [LEQVIO: Affordability & Coverage | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/affordability-and-coverage#:~:text=For%20all%20Medicare%20patients%2C,no%20prior%20authorization%20is%20required)

Note: The two manufacturer sources differ. The affordability page states, under its Medicare tab, which describes traditional Medicare, that no prior authorization is required for all Medicare patients (as captured on November 14, 2026). The Buy-and-Bill 5-Step Guide states that patients with traditional Medicare will likely not require prior authorization and that patients with Medicare Advantage or commercial insurance may need to submit one.

<a id="leqvio-prior-authorization-criteria"></a>

### What prior authorization criteria do plans use for Leqvio?

> “PA criteria may vary by plan, but some examples of criteria may include proof of 
> medical necessity based on the patient’s condition (which is an approved indication), 
> treatment history, and if the patient’s LDL-C level is above guideline-recommended 
> threshold.* Always review and confirm the PA criteria specified by the plan.”

Source: [LEQVIO: Buy-and-Bill 5-Step Guide, page 5, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11608875_LEQ_Buy_and_Bill_5_Step_Guide-Digital-Label_Update-2-26/FA-11608875.PDF#page=5)

> “*Guideline-recommended LDL-C threshold—ASCVD: <70 mg/dL; increased risk of ASCVD: <100 mg/dL.”

Source: [LEQVIO: Buy-and-Bill 5-Step Guide, page 5, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11608875_LEQ_Buy_and_Bill_5_Step_Guide-Digital-Label_Update-2-26/FA-11608875.PDF#page=5)

Note: The passages are from the Buy-and-Bill 5-Step Guide (dated 2-26 in its address) that the practice resources page links.

<a id="leqvio-coverage-denial"></a>

### What can be done if a plan denies Leqvio coverage?

> “If LEQVIO is not covered 
> by the plan, submit a letter 
> of medical necessity or 
> medical exception. If that 
> is not accepted, submit a 
> letter of appeal.”

Source: [LEQVIO: Prior Authorization & Appeals Guide, page 3, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612139_LEQ_PA_and_Appeals_Guide-Digital-Label_Update-2-26/FA-11612139.PDF#page=3)

> “Medical necessity:
> If your patient’s health insurance provider does not grant them access to LEQVIO® due to plan 
> requirements, a letter of medical necessity along with documentation of clinical need may be required to 
> gain access. 
> Medical exception:
> If your patient’s health insurance provider excludes or has not made a coverage decision on LEQVIO, a 
> medical exception process may be followed to determine payer coverage. At a minimum, this will require 
> you to submit a letter of medical exception along with documentation of clinical need.”

Source: [LEQVIO: Prior Authorization & Appeals Guide, page 5, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11612139_LEQ_PA_and_Appeals_Guide-Digital-Label_Update-2-26/FA-11612139.PDF#page=5)

> “If coverage is delayed or denied for commercial patients, reach out to the LEQVIO<sup>®</sup> Service Center for more information on patient affordability support options.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=If%20coverage%20is%20delayed%20or,on%20patient%20affordability%20support%20options.)

## Patient support

<a id="leqvio-service-center"></a>

### What support does the Leqvio Service Center offer?

> “Specialists provide support with insurance coverage, billing and coding information, and patient affordability options
> Our team is equipped to assist every member of your office staff in getting patients started on LEQVIO”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=Specialists%20provide%20support%20with%20insurance,getting%20patients%20started%20on%20LEQVIO)

> “Call 1-833-LEQVIO2 (1-833-537-8462) M-F 8:00 AM to 8:00 PM (ET) to get started with the LEQVIO<sup>®</sup> Service Center.”

Source: [LEQVIO: Practice Resources | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/practice-resources#:~:text=Call%201%2D833%2DLEQVIO2%20%281%2D833%2D537%2D8462%29%20M%2DF%208%3A00,Service%20Center.)

<a id="leqvio-start-form"></a>

### How do I enroll a patient in Leqvio support services (Start Form)?

> “Download and fax our single-page Patient Start Form to 1-877-LEQVIO8 (1-877-537-8468)”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=Download%20and%20fax%20our%20single%2Dpage%20Patient%20Start%20Form%20to%201%2D877%2DLEQVIO8%20%281%2D877%2D537%2D8468%29)

> “Once the Start Form is received by the LEQVIO Service Center, your Access Specialist will check the patient’s insurance  
> coverage, including available options to acquire the product, identify prior authorization requirements, and assess eligibility for 
> financial assistance.”

Source: [LEQVIO: Patient Start Form, page 1, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11485661-1%20LEQVIO%20Service%20Center%20Start%20Form%20-%2010-25/FA-11485661-1.PDF#page=1)

> “Once this form is completed, we can offer full-service support, including:
> • Insurance coverage review (includes benefits verification, prior authorization/appeals research)
> • Benefits reverification approximately 30 days prior to patient’s next treatment date
> • Patient affordability support”

Source: [LEQVIO: Patient Start Form, page 1, captured 2026-11-14](https://www.cdn.fuse.novartis.com/FA-11485661-1%20LEQVIO%20Service%20Center%20Start%20Form%20-%2010-25/FA-11485661-1.PDF#page=1)

<a id="leqvio-care-program"></a>

### What is the Leqvio Care Program?

> “Patients can enroll in dedicated phone support from the LEQVIO Care Program—an optional program to help patients start and stay on track with their treatment plan. When enrolled, patients on therapy have access to:
>
> One-on-one support by dedicated specialists
> Injection appointment reminders
> Helpful tools, lifestyle tips, and motivation through text, mail, and email”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=Patients%20can%20enroll%20in%20dedicated,through%20text%2C%20mail%2C%20and%20email)

> “The LEQVIO Care Program is a patient support program and is not intended to take the place of medical or clinical advice from a health care provider.”

Source: [LEQVIO: Novartis Patient Support | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/novartis-patient-support#:~:text=The%20LEQVIO%20Care%20Program%20is,from%20a%20health%20care%20provider.)

## Related pages
- [Medical information: Leqvio (inclisiran): All indications](https://www.evicenter.com/medical-information/leqvio)
- [Indication](https://www.evicenter.com/medical-information/leqvio/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/leqvio/pharmacology)
- [Clinical trials](https://www.evicenter.com/medical-information/leqvio/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/leqvio/safety)
- [Specific populations](https://www.evicenter.com/medical-information/leqvio/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/leqvio/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/leqvio/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/leqvio/storage-and-supply)
